Multiple analysts have issued price targets for $GPC recently. We have seen 5 analysts offer price targets for $GPC in the last 6 months, with a median target of $135 ...
ROCKVILLE, Md., July 24 (Reuters) - U.S. regulators should wait for more data before deciding whether to approve GPC Biotech AG's proposed prostate cancer pill Orplatna, an advisory panel said on ...
GENUINE PARTS ($GPC) is expected to release its quarterly earnings data on Tuesday, February 18th before market open, per Finnhub. Analysts are expecting revenue of ...
ROCKVILLE, Md., July 24 (Reuters) - U.S. regulators should wait for final survival data before deciding whether to approve GPC Biotech AG's proposed prostate cancer pill Orplatna, an advisory panel ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback